title: The content of the LRS chamber provides a new quality tool for the characterization of the donor platelet profile.
abstract: Cobe Trima version 4 is an apheresis system designed for the collection of combinations of Red Blood Cells (RBC), Platelets (PLT) and plasma components from a single donor. The validation of this apheresis system for PLT components in our institution evidenced the LRS efficacy, as leucoreduction was attained on a 100% basis. However, there were some unexpected occurrences regarding the PLT content. Certain donations showed large disagreements between programmed and obtained yields, not being found clear reasons for those outcomes. Furthermore, the mean platelet volume (MPV) was relatively low when compared with other platelets components produced by other methodologies. An investigation was initiated in order to know whether these shortcomings were donor or process/instrument related. A link was established between the raw material (donor), the process/instrument and the final product, and a new tool was introduced by the study of the LRS chamber. The LRS chamber content was assessed and the PLT cellular indices and PLT aggregation states compared with those obtained from the respective donor and the final product from the same origin. The storage stability of the final products was also analyzed based on these same tests to investigate if the initial low MPV had any deleterious effect during the shelf life of the components. Twenty five plateletpheresis donors, three of them new ones, were randomly selected for this study. For the first time, the content of the LRS chamber was used as a quality tool for identification of the cause of unexpected yields. Large aggregates remained in the LRS chamber in certain donors who were prone to undergo spontaneous aggregation, making the platelet yields low and platelet MPV very small. Based on repeated failures and on this new quality parameter showing LRS chamber abnormality, two donors were temporarily deferred from the panel. While it was not possible to identify the causes, it is appropriate to raise the question whether these profiles were Trima version 4 specific or not. Hence, further investigation is needed for a better clarification. In short, the simultaneous analysis of products and LRS content provided useful information not only for the characterization of donor-related phenomena but also helped in the identification of potential shortcomings in the machine performance allowing for remedial action to be taken on evidence based data.
authors.affiliation: Centro Regional de Sangue de Lisboa, Instituto Português do Sangue, Avenida do Brasil, 53, Pav. 17, 1700 Lisboa, Portugal. evasconcelos@netcabo.pt
authors.forename: E
authors.initials: E
authors.lastname: Vasconcelos
authors.forename: A P
authors.initials: AP
authors.lastname: Sousa
authors.forename: J
authors.initials: J
authors.lastname: Seghatchian
authors.forename: R
authors.initials: R
authors.lastname: Maurício
authors.forename: A C
authors.initials: AC
authors.lastname: Figueiredo
authors.forename: C
authors.initials: C
authors.lastname: Leitão
authors.forename: G
authors.initials: G
authors.lastname: Sousa
mesh_terms: D001782:Blood Donors; D001792:Blood Platelets / Q000166:cytology; D006801:Humans; D010974:Platelet Aggregation; D010983:Plateletpheresis / Q000295:instrumentation / Q000379:methods; D011786:Quality Control